Main Article Content
Introduction: Preterm birth (PTB) is a major determinant of neonatal mortality and morbidity. Preterm babies are prone to serious illness or death during the neonatal period. PTB is one of the unresolved problems in clinical obstetrics and one of the greatest threats to the developing fetus, there is need to determine predictive biomarker for preterm delivery. Therefore present study aimed to assess serum levels of ceruloplasmin and Alkaline phosphatase in preterm and full-term delivery.
Materials and Methods: The present study includes total 80 subjects that comprise forty women presenting with preterm onset of labor followed by delivery and forty women who delivered at term served as controls. Blood Samples from the subjects were obtained for ceruloplasmin and Alkaline phosphatase estimation, when patient was in labor. Serum ceruloplasmin and alkaline phosphatase measured spectrophotometrically. Serum ceruloplasmin was estimated by Herbert A Ravin and Henry et al. method. Serum alkaline phosphatase was estimated by Kinetic p-NPP method.
Results: Serum ceruloplasmin levels were significantly increased (P<0.001) in preterm delivery as compared to full term delivery. Alkaline phosphatase levels are significantly increased in preterm delivery (p<0.001) as compared to full term delivery.
Conclusion: Our study showed that elevated levels of ceruloplasmin and alkaline phosphatase may be associated with preterm delivery in asymptomatic pregnant women. The elevated ALP may be due to mild chronic subclinical infection which may be responsible for preterm delivery. Ceruloplasmin is acute phase reactant, increased due to an antioxidant defence mechanism against oxidative stress.
Nandini MD, Shetty HV, Rupakala BV, Usha SMR, Priyadarshini KS, Manjula HS, Victoria Ksh. Study of serum ferritin levels in preterm labor. International Journal of Recent Trends in Science And Technology. 2015;14(2):477-48.
Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization. 2010;88(1):31–38.
Barros FC, Papageorghiou AT, Victora CG, Noble JA, Pang R, Iams J, et al. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr. 2015;169(3): 220-9.
Michael W. Varner, M. Sean Esplin. Current understanding of genetic factors in preterm birth BJOG: An International Journal of Obstetrics and Gynaecology. 2005;112(1):28–31.
Georgiou HM, Di Quinzio MK, Permezel M, Brennecke SP. Predicting preterm labour: Current status and future prospects. Dis Markers. 2015;1-9.
Yulia A, Wijesiriwardana A. Extremely high isolated maternal alkaline phosphatase serum concentration -2 case reports .International Journal of Pregnancy & Child Birth. 2017;2(4):111-113.
Rathore S, Gupta A, Singh B, Rathore R Comparative study of trace elements and serum ceruloplasmin level in normal and pre-eclamptic pregnancies with their cord blood Biomedical Research. 2011;22(2): 209-212.
Herbert A, Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med. 1961;58: 161–8.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75‑84.
Roberts CL, Morris JM, Rickard KR, Giles WB, Simpson JM, Kotsiou G, et al. Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]. BMC Pregnancy Childbirth. 2011;11:19.
Ogino M, Hiyamuta S, Takatsuji-Okawa M, Tomooka Y, Minoura S. Establishment of a prediction method for premature rupture of membranes in term pregnancy using active ceruloplasmin in cervicovaginal secretion as a clinical marker. J Obstet Gynaecol Res. 2005; 31:421-6
Vitoratos N, Botsis D, Christodoulacos C, Contoravdis A, Dalamaga A, Chryssicopoulos A. Role of serum ceruloplasmin and its ferroxidase activity on preterm labor. Gyn Obs Invest. 1998;46: 34-6.
Kadota A, Tandogan T, Aydin Y, Sen C, Turgay F, Eren N et al. Late pregnancy associated plasmaprotein a levels decrease in preterm labor. J Matern Fetal Neonatal Med. 2011;24:923-7.
Kalra R, Kalra VB, Nacht S, Cartwright OE. The role of ceruloplasmin in iron metabolism. J Clin Inves.t 1970;49:2408-17.
Singh B, Goswami B, Gupta N, Bajaj AD, MallikaV. Potential biochemical markers for preterm labor: A pilot study North India. Indian J Clin Biochem. 2010;26:41-5.
Tripathi R, Tyagi S, Singh N, Mala Y, Singh C, Bhalla P, et al. Can preterm labour be predicted in low risk pregnancies? Role of clinical, sonographic and biochemical markers. Journal of Pregnancy. 2014;7(9):1-7-(38).
Meyer RE, Thompson SJ, Addy CL, Garrison CZ, Best RG. Maternal serum placental alkaline phosphatase level and risk for preterm delivery. Is J Obstet Gynecol. 1995;173:181-6.
Moawad AH, Goldenberg RL, Mercer B, Meis PJ, Iams JD, Das A, et al. The preterm prediction study: The value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol. 2002;186:990-6.
Huras H, Ossowski P, Jach R, Reron A. Usefulness of marking alkaline phosphatase and C-reactive protein in monitoring the risk of preterm delivery. Med Sci Monit. 2011;17.
Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad A, Das A, et al. The preterm prediction study: Toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 2001;185:643-51.
Ozgu-Erdinc AS, Cavkaytar S, Aktulay A, Buyukkagnici U, Erkaya S, Danisman N. Mid-trimester maternal serum and amniotic fluid biomarkers for the prediction of preterm delivery and intrauterine growth retardation. J Obstet Gynaecol Res. 2013;40:1540-6.
Hurmale AK, Deshwali SK, Singh J. Study of serum iron, serum zinc and serum alkaline phosphatase in premature delivery. Int. J. Med. Sci. Educ. 2019;6(3):26-30.